← NOVAVAX INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $15.4m |
$31.2m
+103.06%
|
$34.3m
+9.98%
|
$18.7m
-45.57%
|
$475.6m
+2448.48%
|
$1.1b
+141.02%
|
$2.0b
+72.89%
|
$983.7m
-50.36%
|
$682.2m
-30.65%
|
$1.1b
+64.69%
|
$413.8m
-63.17%
|
|
| Cost of Goods and Services Sold | $237.9m |
$168.4m
-29.21%
|
$173.8m
+3.18%
|
$104.8m
-39.68%
|
$0
-100.00%
|
$0 | $902.6m |
$343.8m
-61.92%
|
$202.7m
-41.02%
|
$73.0m
-63.97%
|
$88.5m
+21.22%
|
|
| Gross Profit (Calculated) (derived) | ($222.6m) |
($137.3m)
+38.33%
|
($139.5m)
-1.64%
|
($86.2m)
+38.24%
|
$475.6m
+651.97%
|
$1.1b
+141.02%
|
$1.1b
-5.85%
|
$639.9m
-40.70%
|
$479.4m
-25.08%
|
$1.1b
+119.10%
|
— | |
| Research and Development Expense | $237.9m | $168.4m | $173.8m | $113.8m | $747.0m | $2.5b | $1.2b | $737.5m | $391.2m | $342.3m | $340.3m | |
| General and Administrative Expense | $46.5m | $34.5m | $34.4m | $34.4m | $145.3m | $298.4m | $488.7m | $468.9m | $337.2m | $157.5m | $488.7m | |
| Amortization of Intangible Assets | $800k | $2.2m | $700k | $700k | $600k | $400k | — | — | — | — | — | |
| Restructuring Costs | $3.6m | — | — | — | — | — | — | — | — | — | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | ($269.1m) |
($171.7m)
+36.19%
|
($173.9m)
-1.29%
|
($120.6m)
+30.67%
|
($416.7m)
-245.59%
|
($1.7b)
-304.73%
|
($644.7m)
+61.77%
|
($566.5m)
+12.13%
|
($248.9m)
+56.06%
|
$452.8m
+281.90%
|
($136.3m)
-130.10%
|
|
| Interest Expense, Debt | $12.5m | $13.6m | $13.6m | $13.6m | $13.6m | $13.6m | $14.0m | $11.5m | $10.4m | $11.5m | $21.9m | |
| Investment Income, Net | $2.1m | $1.9m | $2.7m | $1.5m | $1.0m | $1.4m | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | ($31k) | $67k | $108k | ($13k) | $12.6m | ($8.2m) | $11.0m | $37.9m | $40.4m | $40.6m | — | |
| Interest Expense (non-operating) | $13.0m | $14.1m | $13.6m | $13.6m | $15.1m | $21.1m | $19.9m | $14.4m | $20.1m | $22.5m | $21.9m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $269.1m | $171.7m | $173.9m | $120.6m | $416.7m | ($1.6b) | ($712.2m) | ($629.0m) | ($261.9m) | $426.3m | ($245.3m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $269.1m | $171.7m | $173.9m | $120.6m | $416.7m | ($1.7b) | ($653.6m) | ($543.0m) | ($176.6m) | $442.2m | ($245.3m) | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | — | $4.3m | ($12k) | $12.3m | $1.9m | $2.4m | |
| Income Tax Expense (Benefit) | — | — | — | — | — | $29.2m | $4.3m | $2.0m | $10.9m | $1.9m | $2.4m | |
| Net Income (Loss) Attributable to Parent | ($280.0m) |
($183.8m)
+34.36%
|
($184.7m)
-0.53%
|
($132.7m)
+28.18%
|
($418.3m)
-215.21%
|
($1.7b)
-316.91%
|
($657.9m)
+62.27%
|
($545.1m)
+17.16%
|
($187.5m)
+65.60%
|
$440.3m
+334.83%
|
($247.7m)
-156.26%
|
|
| Earnings Per Share, Basic | — | — | — | ($5.51) | ($7.27) | ($23.44) | ($8.42) | ($5.41) | ($1.23) | $2.72 | ($1.53) | |
| Earnings Per Share, Diluted | ($1.03) | ($0.63) | ($0.50) | ($5.51) | ($7.27) | ($23.44) | ($8.42) | ($5.41) | ($1.23) | $2.58 | ($1.53) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 74.4m | 78.2m | 100.8m | 152.2m | 162.0m | 163.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 74.4m | 78.2m | 100.8m | 152.2m | 173.1m | 166.4m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $284.5m | $202.9m | $208.2m | $139.2m | $892.3m | $2.8b | $2.6b | $1.6b | $931.1m | $670.7m | — | |
| Goodwill, Impairment Loss | — | — | — | $0 | — | — | — | $0 | $0 | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.